Exploration of structure-activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment linking and active learning
The macrodomain of severe acute respiratory syndrome coronavirus 2 nonstructural protein 3 is required for viral pathogenesis and is an emerging antiviral target. We previously performed an x-ray crystallography-based fragment screen and found submicromolar inhibitors by fragment linking. However, these compounds had poor membrane permeability and liabilities that complicated optimization. Here, we developed a shape-based virtual screening pipeline-FrankenROCS. We screened the Enamine high-throughput collection of 2.1 million compounds, selecting 39 compounds for testing, with the most potent binding with a 130 μM median inhibitory concentration (IC<sub>50</sub>). We then paired FrankenROCS with an active learning algorithm (Thompson sampling) to efficiently search the Enamine REAL database of 22 billion molecules, testing 32 compounds with the most potent binding with a 220 μM IC<sub>50</sub>. Further optimization led to analogs with IC<sub>50</sub> values better than 10 μM. This lead series has improved membrane permeability and is poised for optimization. FrankenROCS is a scalable method for fragment linking to exploit synthesis-on-demand libraries.
Authors
- Patrick Riley (ORCID: https://orcid.org/0000-0003-0797-0272)
- Yurii S. Moroz (ORCID: https://orcid.org/0000-0001-6073-002X)
- Brian Goldman
- Brian K. Shoichet (ORCID: https://orcid.org/0000-0002-6098-7367)
- Stefan Gahbauer (ORCID: https://orcid.org/0000-0002-3115-9757)
- Yagmur Umay Doruk (ORCID: https://orcid.org/0000-0002-3388-7803)
- G.J. Correy (ORCID: https://orcid.org/0000-0001-5155-7325)
- Adam R. Renslo (ORCID: https://orcid.org/0000-0002-1240-2846)
- James S. Fraser (ORCID: https://orcid.org/0000-0002-5080-2859)
- Takaya Togo (ORCID: https://orcid.org/0000-0003-0243-0760)
- Dmytro S. Radchenko (ORCID: https://orcid.org/0000-0001-5444-7754)
- Alan Ashworth (ORCID: https://orcid.org/0000-0003-1446-7878)
- Trevor J. Kramer
- W. Patrick Walters (ORCID: https://orcid.org/0000-0003-2860-7958)
- Moira M. Rachman (ORCID: https://orcid.org/0000-0003-3671-8885)
- Molly Schmidt (ORCID: https://orcid.org/0000-0002-8535-6764)
- Brian Kelley
- Priyadarshini Jaishankar (ORCID: https://orcid.org/0009-0005-2013-8941)
- Maisie GV Stevens (ORCID: https://orcid.org/0009-0004-9732-0349)
Institutions
- University of California, San Francisco (US)
- Taras Shevchenko National University of Kyiv (UA)
- Relay Therapeutics (United States) (US)
- UCSF Helen Diller Family Comprehensive Cancer Center (US)
- Enamine (Ukraine) (UA)
Publication Details
- Journal
- Science Advances
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1126/sciadv.ads7187
- Citations
- 17
- Primary Topic
- RNA and protein synthesis mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 12.90